Researchers discover peptide that may reduce rheumatoid arthritisBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7294.1084/a (Published 05 May 2001) Cite this as: BMJ 2001;322:1084
- Xavier Bosch
Patients with rheumatoid arthritis might soon benefit from a treatment based on an endogenously occurring natural peptide known as vasoactive intestinal peptide.
A team of researchers led by Mario Delgado from the faculty of biology of the Complutense University of Madrid reported this month in Nature Medicine (2001;7:563-8) that administration of the peptide in mice with a rheumatoid arthritis-like disease strikingly suppressed clinical joint disease. It also seemed to block both the inflammatory and autoimmune components inherent in the disorder.
By immunising mice with type II collagen, the researchers induced …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial